Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
CRMD is in the long-term up 2680% in 2 years.
Description: CorMedix Inc., a development-stage pharmaceutical and medical device company, intends to in-license, develop, and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases. The company?s product candidates include CRMD003 (Neutrolin) and CRMD004, an antimicrobial/antifungal and anticoagulant combination in liquid and gel formulations used for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-22.5%||Sales Growth - Q/Q||-63.53%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-94.73%||ROE||-121.62%||ROI|
|Current Ratio||4.57||Quick Ratio||4.35||Long Term Debt/Equity||Debt Ratio||0.28|
|Gross Margin||-83.65%||Operating Margin||-5512.02%||Net Profit Margin||-4441.35%||Dividend Payout Ratio|
|Cash From Financing Activities||6.83 M||Cash From Investing Activities||-10 K||Cash From Operating Activities||-2.35 M||Gross Profit||10 K|
|Net Profit||-5.5 M||Operating Profit||-5.5 M||Total Assets||9.75 M||Total Current Assets||9.69 M|
|Total Current Liabilities||2.12 M||Total Debt||Total Liabilities||2.16 M||Total Revenue||30 K|
|High 52 week||13.25||Low 52 week||0.21||Last close||8.2||Last change||-2.26%|
|RSI||37.07||Average true range||0.49||Beta||0.7||Volume||213.35 K|
|Simple moving average 20 days||-7.81%||Simple moving average 50 days||-1.14%||Simple moving average 200 days||27.2%|
|Performance Week||-11.35%||Performance Month||-12.49%||Performance Quart||11.41%||Performance Half||-16.75%|
|Performance Year||2546.87%||Performance Year-to-date||535.66%||Volatility daily||3.36%||Volatility weekly||7.52%|
|Volatility monthly||15.41%||Volatility yearly||53.4%||Relative Volume||420.72%||Average Volume||408.2 K|
|New High||New Low|
2019-11-15 05:12:20 | Edited Transcript of CRMD earnings conference call or presentation 14-Nov-19 9:30pm GMT
2019-11-14 17:35:10 | CorMedix CRMD Reports Q3 Loss, Misses Revenue Estimates
2019-11-14 16:05:00 | CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
2019-11-06 10:30:03 | CorMedix CRMD May Report Negative Earnings: Know the Trend Ahead of Q3 Release
2019-11-06 08:15:00 | CorMedix Inc. Announces a Change to its Senior Leadership
2019-10-24 07:55:22 | Have Insiders Been Buying CorMedix, Inc. NYSEMKT:CRMD Shares This Year?
2019-10-16 08:15:00 | CorMedix Completes Successful CMC Interaction with the FDA
2019-09-26 16:30:00 | CorMedix Inc. to Present at the Cantor 2019 Global Healthcare Conference
2019-09-26 08:15:00 | CorMedix Inc. Announces Exercises of Outstanding Warrants
2019-09-24 19:14:01 | Biggest Hedge Fund Buys of September
2019-09-18 10:17:01 | Should You Worry About CorMedix, Inc.'s NYSEMKT:CRMD CEO Pay?
2019-09-03 16:30:00 | CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference
2019-08-14 19:21:53 | CorMedix Inc. Announces Exchange Agreement With Its Largest Investor
2019-08-14 15:49:54 | Edited Transcript of CRMD earnings conference call or presentation 13-Aug-19 8:30pm GMT
2019-08-13 17:45:09 | CorMedix CRMD Reports Q2 Loss, Misses Revenue Estimates
2019-08-13 13:47:22 | Is CorMedix NYSEMKT:CRMD Weighed On By Its Debt Load?
2019-08-06 10:30:02 | CorMedix CRMD May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2019-07-31 11:28:05 | 7 A-Rated Stocks Under $10
2019-07-09 11:42:54 | Why CorMedix Shares Are Rallying
2019-07-09 08:15:00 | CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data
2019-06-28 14:19:40 | 18 Stocks Joining The Russell Indices
2019-06-26 08:30:00 | CorMedix Inc. Set to Join the Russell 2000® Index
2019-06-10 08:30:00 | CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10
2019-05-13 22:28:56 | Edited Transcript of CRMD earnings conference call or presentation 13-May-19 8:30pm GMT
2019-05-13 17:45:09 | CorMedix CRMD Reports Q1 Loss, Tops Revenue Estimates
2019-05-13 16:41:01 | CorMedix: 1Q Earnings Snapshot
2019-05-13 16:05:00 | CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
2019-05-08 09:07:01 | Should You Take Comfort From Insider Transactions At CorMedix, Inc. NYSEMKT:CRMD?
2019-04-11 16:15:00 | CorMedix Notified of Compliance with NYSE American Listing Requirements
2019-04-02 08:05:54 | Is CorMedix, Inc. NYSEMKT:CRMD Overpaying Its CEO?
2019-03-25 16:15:00 | CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split
2019-03-11 16:35:00 | CorMedix Inc. to Present at Roth and Oppenheimer & Co. Investor Conferences
2019-03-11 10:30:02 | Will CorMedix CRMD Report Negative Q4 Earnings? What You Should Know
2019-03-04 08:00:00 | CorMedix Inc. Appoints Alan W. Dunton, M.D. to Board of Directors
2019-02-21 07:20:00 | Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
2019-02-20 08:00:00 | Biotech Bounce Just Getting Started